📰 Supercon Technologies News
Supercon Technologies News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Supercon Technologies. Real-time updates on events, politics, business and more.
May 2, 2024
Q1 2024 revenues of $721.7 million, up 5.3% year-over-year ; organic revenue up 1.6% yoy, and constant-exchange rate revenue up 5.5% yoy Q1 2024 GAAP EPS of $0.35; non-GAAP EPS of...
February 17, 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips The Nasdaq is off to a scorching start in 2024. The Nasdaq 100 Index is making ...
February 13, 2024
Q4 2023 revenues of $854.5 million, up 20.6% year-over-year ; organic revenue up 15.9% yoy Q4 2023 GAAP EPS of $1.41, including a $0.99 per share gain on PhenomeX acquisition[1]; Q4 2023...
January 3, 2024
-- Bruker said Wednesday that it has acquired Nion, a company that develops and manufactures scanning transmission electron microscopes. Financial details of the deal were not disclosed. The...
November 2, 2023
Q3 2023 revenues of $742.8 million, up 16.3% year-over-year ; organic revenue up 10.9% yoy Q3 2023 GAAP EPS $0.60; non-GAAP EPS $0.74, up 12.1% yoy Bruker increases FY 2023 revenue guidance to...
November 2, 2023
Non-GAAP EPS up by 12.1% YoY; FY 2023 Revenue Guidance Increased
June 16, 2023
Revvity (NYSE:RVTY – Get Rating) and Bruker (NASDAQ:BRKR – Get Rating) are both large-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, valuation, risk, dividends, profitability and analyst recommendations. Profitability This table compares Revvity and Bruker’s net margins, return on […]
June 16, 2023
Revvity (NYSE:RVTY – Get Rating) and Bruker (NASDAQ:BRKR – Get Rating) are both large-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, institutional ownership, valuation, profitability, earnings, analyst recommendations and dividends. Profitability This table compares Revvity and Bruker’s net margins, return on […]
June 4, 2023
Standard BioTools (NASDAQ:LAB – Get Rating) and Bruker (NASDAQ:BRKR – Get Rating) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, dividends, risk, institutional ownership, valuation, profitability and analyst recommendations. Analyst Recommendations This is a summary of recent ratings and price […]